Lamivudine treatment in patients with decompensated hepatitis B cirrhosis: for whom and when?
- 1 August 2000
- journal article
- editorial
- Published by Elsevier in Journal of Hepatology
- Vol. 33 (2) , 329-332
- https://doi.org/10.1016/s0168-8278(00)80376-1
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- Update on Diagnosis, Management, and Prevention of Hepatitis B Virus InfectionClinical Microbiology Reviews, 1999
- Hepatitis B and C virus infection, alcohol drinking, and hepatocellular carcinoma: A case-control study in ItalyHepatology, 1997
- Survival and prognostic factors in 366 patients with compensated cirrhosis type B: a multicenter studyJournal of Hepatology, 1994
- Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liverGastroenterology, 1992
- Hepatitis B: Evolving Epidemiology and Implications for ControlSeminars in Liver Disease, 1991
- Incidence, determinants and significance of delayed clearance of serum HBsAg in chronic hepatitis B virus infection: A prospective studyHepatology, 1991
- Influence of Hepatitis Delta Virus Infection on Progression to Cirrhosis in Chronic Hepatitis Type BThe Journal of Infectious Diseases, 1987
- Survival in Chronic Hepatitis BAnnals of Internal Medicine, 1984
- Prognostic Value of Child-Turcotte Criteria in Medically Treated CirrhosisHepatology, 1984
- Transection of the oesophagus for bleeding oesophageal varicesBritish Journal of Surgery, 1973